Storys zum Thema Products

Folgen
Keine Story zum Thema Products mehr verpassen.
Filtern
  • 01.09.2005 – 15:18

    Procter & Gamble

    P&G Finalises Acquisition of Sanofi-Aventis' Oral Care Brands

    Geneva, Switzerland (ots/PRNewswire) - - Pharmacy Channel Capability - Important Step to Oral Care Leadership The Procter & Gamble Company (NYSE: PG) today announced that it has finalised the acquisition of Sanofi-aventis' global portfolio of trusted oral care brands for an undisclosed sum. "Fluocaril and Parogencyl, are leading pharmacy brands in Europe, Asia and Africa with an incredibly loyal consumer ...

  • 25.08.2005 – 10:07

    Nissan Motor Co., Ltd.

    Nissan Collaborates on Next Generation In-Car Safety Systems

    Trappes, France (ots/PRNewswire) - Nissan has been collaborating in an exploratory project to develop bone-scanning technology which will maximise the protection offered to occupants in the event of a car crash. Nissan's Technical Centre Europe (NTCE) is one of several automotive organisations involved in the bone-scanning project, called BOSCOS (Bone Scanning for Occupant Safety). The aim of the project is to ...

  • 23.08.2005 – 23:51

    InnoCentive

    /C O R R E C T I O N -- InnoCentive/

    Beijing and Moscow (ots/PRNewswire) - In the news release, InnoCentive Continues to Grow Its Virtual Scientific Network by Adding Leading Universities Throughout China and Russia, issued earlier today by InnoCentive over PR Newswire, we are advised by the client that the quote in the third graph should be attributed to "Mr. Ali Hussein" rather than "Mr. Hussein" as originally issued inadvertently. Complete, corrected ...

  • 23.08.2005 – 09:03

    JPMorgan

    JPMorgan Joins Bloomberg Multi-Dealer Interest Rate Swaps Platform

    London (ots/PRNewswire) - JPMorgan (NYSE:JPM) and Bloomberg announced today that JPMorgan has joined Bloomberg SwapTrader, the live multi-dealer trading platform for euro denominated Interest Rate Swaps. This platform offers end-user clients the ability to trade interest rate swaps on-line through a multi-dealer trading system featuring the 'Request-For-Quote' (RFQ) ...

  • 15.08.2005 – 16:13

    Orange Communications SA

    Telecom FL MOBILE!: Irresistible offers from 15 August 2005

    15 August 2005, Telecom FL and Orange (Liechtenstein) AG, a subsidiary of Orange Switzerland, are launching new and attractive MOBILE products under the brand name Telecom FL MOBILE. Vaduz/Lausanne (ots) - Telecom FL and Orange (Liechtenstein) AG, together, are offering their customers in Liechtenstein mobile communication services. The "Powered by Orange" MOBILE offers provide tailor-made subscriptions, which are ...

  • 10.08.2005 – 20:37

    Ross River Minerals Inc

    New Grid Extends Copper Mineralisation at El Pulpo

    Vancouver, Canada (ots/PRNewswire) - Ross River Minerals Inc. (TSX-V: RRM) (the "Company") has received analyses of 34 lithogeochemical samples from the Cetolla area. Copper analyses ranged from 44.30 ppm Cu to greater than 10,000 ppm Cu (approximately 1%). Four samples exceeded the detection limit of 10,000 ppm Cu. Molybdenum analytical results ranged from 1.07 ppm Mo to 1,902.64 ppm Mo. Silver analyses ranged from ...

  • 10.08.2005 – 10:29

    Fast Search & Transfer ASA

    FAST Introduces a New Standard for Application-Based Search

    Oslo, Norway (ots/PRNewswire) - - Enhanced Version of FAST InStream Offers ISVs Increased Performance, Simple Integration Capabilities and Broadened Feature Set Fast Search & Transfer(TM) (FAST(TM)), (OSE: FAST, OTC: FASRF) the leading developer of enterprise search and real-time alerting technologies, today announced the general availability of FAST InStream(TM) Version 4.2. FAST InStream is an ...

  • 28.07.2005 – 15:53

    Boehringer Ingelheim

    Positive Opinion in Europe for Tipranavir

    Rio De Janeiro, Brazil and Ingelheim, Germany (ots/PRNewswire) - - New Data Support its Use as Powerful Treatment Against HIV Drug Resistance RIO DE JANEIRO, Brazil and INGELHEIM, Germany, July 28 /PRNewswire/ -- Boehringer Ingelheim announced today that the CHMP (Committee for Medicinal Products for Human Use) in London has issued a positive opinion for tipranavir, a non-peptidic protease inhibitor, to ...